SRTS Sensus: Long-Term Debt to Capital Coefficient

Sensus Healthcare, Inc. (SRTS) retains key radiation therapy engineers, minimizing staff turnover. The long-term debt financial leverage history helps track sector stability, where the 0.00 metric confirms the current level. Global sales for Sensus Healthcare, Inc. (SRTS) are limited by certification complexities and Asian electronics imports. Revenues are based on the sale of skin cancer treatment systems and regular equipment maintenance services.
Summary analytical data breakdowns for Sensus Healthcare, Inc. (SRTS)

Sensus Healthcare, Inc. (SRTS) dominates the non-invasive skin cancer therapy segment, avoiding price wars with surgical alternatives. Analyzing the long-term debt-to-equity ratio reveals the business's dependence on external loans. This metric compares liabilities with maturities exceeding one year against the market value of equity. An increasing ratio signals a shift toward debt financing, while high values elevate the risk of asset value depreciation.